Market Place
Sourcing Support
PureTech Presents IPF Research And LYT-100 Analysis At CHEST
08 Oct 2024 //
BUSINESSWIRE
PureTech to Present at CHEST 2024 Annual Meeting
01 Oct 2024 //
BUSINESSWIRE
PureTech Completes LYT-100 IPF ELEVATE 2b Enrollment
16 Apr 2024 //
BUSINESSWIRE
PureTech Presents Data from LYT-100 Trial in Annual Meeting
11 Oct 2023 //
BUSINESSWIRE
PureTech Presents Data for LYT-100 at ERSI Congress 2022
06 Sep 2022 //
BUSINESSWIRE
PureTech Presents Data for LYT-100 (Deupirfenidone) Design of Dose-Ranging
05 Sep 2022 //
INVESTOR
PureTech Initiates Late-Stage Study of LYT-100 in IPF and Advances LYT-200
30 Jun 2022 //
BUSINESSWIRE
PureTech’s LYT-100 Shows 50% Reduction against GI-Related AEs vs Pirfenidone
05 Jan 2022 //
BUSINESSWIRE
PureTech Announces Publication of Phase 1 Results for LYT-100
16 Nov 2021 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.